Diagnosis, Screening, Prevention, and Treatment of Osteoporosis

Mauck, Karen F.; Clarke, Bart L.
May 2006
Mayo Clinic Proceedings;May2006, Vol. 81 Issue 5, p662
Academic Journal
Osteoporosis is the most common bone disease In humans and affects both men and women. The clinical and public health implications of the disease are substantial because of the mortality, morbidity, and cost of medical care associated with osteoporotic fractures. Osteoporosis is diagnosed on the basis of a low-impact or fragility fracture or low bone mineral density, which was best assessed by central dual-energy x-ray absorptiometry. Both non-pharmacological therapy (calcium and vitamin D supplementation, weight-bearing exercise, and fall prevention) and pharmacological treatments (antiresorptive and anabolic agents) may be helpful in the prevention and treatment of osteoporosis. Therefore, clinicians need to be vigilant in instituting primary prevention measures for those at high risk for osteoporosis and in instituting treatment for patients diagnosed as having the disease either by screening or a history of fracture. This article provides an overview of the diagnosis, screening, prevention, and treatment of osteoporosis.


Related Articles

  • An overview of osteoporosis. Sutcliffe, Anne // Nursing Standard;9/21/2005, Vol. 20 Issue 2, p58 

    This article explains the pathogenesis and diagnosis of osteoporosis and treatment options for patients with the condition. It also discusses service provision and focuses on the nurse's role in treating patients with osteoporosis.

  • P4 medicine and osteoporosis: a systematic review. Kodrič, Klemen; Čamernik, Klemen; Černe, Darko; Komadina, Radko; Marc, Janja // Wiener Klinische Wochenschrift;Dec2016 Supplement, Vol. 128, p480 

    Background: Osteoporosis is the most frequent bone metabolic disease. In order to improve early detection, prediction, prevention, diagnosis, and treatment of the disease, a new model of P4 medicine (personalized, predictive, preventive, and participatory medicine) could be applied. The aim of...

  • The Diagnosis and Treatment of Primary Osteoporosis According to Current Guidelines: Unreliable in the Individual Case. Schneider, Peter // Deutsches Aerzteblatt International;1/16/2009, Vol. 106 Issue 3, p4 

    The article presents the author's comment on the article "The Diagnosis and Treatment of Primary Osteoporosis According to Current Guidelines: Unreliable in the Individual Case," by Professor and Doctor Klaus M. Peters and others. According to the author, slim or anorexic individuals are often...

  • Follow-up treatment for osteoporosis after fracture. Hooven, Frederick; Gehlbach, Stephen H.; Pekow, Penelope; Bertone, Elizabeth; Benjamin, Evan // Osteoporosis International;Mar2005, Vol. 16 Issue 3, p296 

    Studies of the management of osteoporosis in older women who have had hip or wrist fractures have found underdiagnosis and undertreatment of the disease. Few such studies have been conducted in the United States, however, and most studies have been confined to a subset of the treatments...

  • New antiosteoporosis agents show promise. Pfeiffer, Naomi // Drug Topics;10/24/2005, Vol. 149 Issue 20, Special section p8 

    This article reports on the latest science on the diagnosis and treatment of osteoporosis from the American Society for Bone and Mineral Research in the U.S. A new drug called AAE581 from Novartis, which aim to prevent the loss of bone mass and strength in a study of osteoporotic monkeys....

  • Is a Calculated Total Hip BMD of Clinical Use? Selby, P. L.; McCloskey, E. V.; Robinson, J.; Smith, I. G.; Potts, B.; Beneton, M. N. C.; Kanis, J. A. // Osteoporosis International;May2000, Vol. 11 Issue 4, p368 

    : The diagnosis of osteoporosis is based on bone mass measurement. To avoid the errors associated with the measurement of spinal bone density the total hip has been accepted as the standard measurement site. This information is not available for many early measurements. We have assessed whether...

  • Steroids and osteoporosis. Cooper, Alun // Update;6/3/2004, Vol. 68 Issue 10, p501 

    It is well documented that long term steroid use can lead to osteoporosis. Researcher Alun Cooper discusses some of issues surrounding bone density monitoring. The use of oral steroids is associated with a significant increase in risk of fracture to the hip and spine. It increases rapidly after...

  • Preface [Hot topic: Osteoporosis (Executive Editor : Paul Morley)]. Morley, Paul // Current Pharmaceutical Design;Dec2003, Vol. 9 Issue 32, p1 

    The present issue of �Current Pharmaceutical Design� is dedicated to osteoporosis. Osteoporosis is characterized by low bone mass and deterioration of bone leading to increased risk of fracture. It is often called the �silent epidemic� because bone loss occurs without...

  • Models for Assessing the Cost-Effectiveness of the Treatment and Prevention of Osteoporosis. Zethraeus, N.; Ben Sedrine, W.; Caulin, F.; Corcaud, S.; Gathon, H. J.; Haim, M.; Johnell, O.; Jönsson, B.; Kanis, J. A.; Tsouderos, Y.; Reginster, J.-Y. // Osteoporosis International;Nov2002, Vol. 13 Issue 11, p841 



Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics